Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)

3/28/25 4:11:57 PM ET

$HCA

Hospital/Nursing Management

Health Care

Get the next $HCA alert in real time by email

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BANK OF AMERICA CORP /DE/

(Last)

(First)

(Middle)

BANK OF AMERICA CORPORATE CENTER

100 N. TRYON STREET

(Street)

CHARLOTTE

28255

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/26/2011

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾⁽²⁾⁽³⁾	07/26/2011		P		670	A	$27.97	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/10/2012		S		477	D	$21.9	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/13/2012		P		477	A	$23.2884	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		S		100	D	$26.58	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		P		100	A	$26.58	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		S		100	D	$26.58	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		P		100	A	$26.58	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		S		100	D	$26.59	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	01/25/2012		P		100	A	$26.59	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/01/2012		S		148	D	$25.1542	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/02/2012		P		148	A	$24.911	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/03/2012		P		1	A	$26.27	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/07/2012		P		32	A	$29	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/13/2012		P		1	A	$27.78	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/14/2012		S		32	D	$25.17	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/14/2012		S		1	D	$25.1	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/17/2012		S		1	D	$25.16	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/22/2012		S		200	D	$25.4089	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	02/22/2012		P		200	A	$25.4637	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		P		1,580	A	$25.28	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		S		80	D	$25.31	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		S		1,300	D	$25.3147	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		S		100	D	$25.315	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/08/2012		S		100	D	$25.315	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/09/2012		P		2	A	$25.63	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/15/2012		S		2	D	$25.34	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/16/2012		S		25	D	$25.33	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	03/19/2012		P		25	A	$25.18	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	04/03/2012		S		112	D	$26.83	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾
Common Stock⁽¹⁾⁽²⁾⁽³⁾	04/03/2012		S		300	D	$26.83	0⁽⁴⁾	I	See Footnotes⁽¹⁾⁽²⁾⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

BANK OF AMERICA CORP /DE/

(Last)

(First)

(Middle)

BANK OF AMERICA CORPORATE CENTER

100 N. TRYON STREET

(Street)

CHARLOTTE

28255

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

BANK OF AMERICA NA

(Last)

(First)

(Middle)

BANK OF AMERICA CORPORATE CENTER

100 NORTH TRYON STREET

(Street)

CHARLOTTE

28255

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

MERRILL LYNCH, PIERCE, FENNER & SMITH INC.

(Last)

(First)

(Middle)

ONE BRYANT PARK

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. This statement is jointly filed by Bank of America Corporation, Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), and Bank of America, N.A. ("BANA") (together, the "Reporting Persons"). Bank of America Corporation holds an indirect interest in the securities listed in this Report by virtue of its 100% ownership of its subsidiaries Merrill Lynch, and BANA. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Securities Exchange Act of 1934 (the "Exchange Act"), or for any other purpose.

2. Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the Exchange Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer or (ii) a member of any group with respect to the Issuer or any securities of the Issuer.

3. Without conceding its status as a greater than 10% beneficial owner or that the reported transactions are subject to disclosure under Section 16(a) of the Exchange Act or short-swing profit recovery under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that the Reporting Persons were greater than 10% beneficial owners and the transactions were subject to Section 16(b) has been or will be remitted to the Issuer.

4. The starting ownership position of the Reporting Persons is not reasonably available to the Reporting Persons and has accordingly been omitted pursuant to Rule 12b-21 under the Exchange Act.

Remarks:

Balance of trades included in attached schedule. (See Exhibit 99.1) Exhibit 99.2 - Joint Filing Agreement

	BANK OF AMERICA CORP /DE/ Andres Ortiz By:Its: Authorized Signatory Andres Ortiz	03/28/2025
	BANK OF AMERICA NA Andres Ortiz By:Its Authorized Signatory Andres Ortiz	03/28/2025
	MERRILL LYNCH, PIERCE, FENNER & SMITH INC. Andres Ortiz By:Its Authorized Signatory Andres Ortiz	03/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $HCA alert in real time by email

Recent Analyst Ratings for

$HCA

Date	Price Target	Rating	Analyst
4/15/2025	$336.00	Outperform → Neutral	Robert W. Baird
12/17/2024	$380.00	Neutral	Analyst
11/25/2024	$400.00 → $320.00	Equal Weight → Underweight	Wells Fargo
11/22/2024		Outperform → Mkt Perform	Raymond James
10/11/2024	$475.00	Overweight	KeyBanc Capital Markets
9/3/2024	$427.00	Equal-Weight	Morgan Stanley
5/30/2024	$396.00	Outperform	Robert W. Baird
3/6/2024	$356.00	Overweight	Barclays

More analyst ratings

Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)

Chat with this insight

Recent Analyst Ratings for
$HCA

$HCA
Press Releases

Fastest customizable press release news feed in the world

HCA Healthcare Reports First Quarter 2025 Results

Two Large Clinical Trials Find a Highly Effective Method to Select Appropriate Antibiotics for Patients Hospitalized With Abdominal or Skin and Soft Tissue Infection

HCA Healthcare Named One of the World's Most Admired Companies by Fortune

$HCA
Leadership Updates

Live Leadership Updates

HCA Healthcare Announces HCA Healthcare Foundation's Support of Girl Scouts Mental Wellness Patch Programs

HCA Healthcare Appoints Jyric Sims President of Company's West Florida Division

HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall

$HCA
SEC Filings

HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

SEC Form DEFA14A filed by HCA Healthcare Inc.

SEC Form DEF 14A filed by HCA Healthcare Inc.

$HCA
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.